Search Results - "Flux, G.D."

Recommendations for Multicentre Clinical Trials Involving Dosimetry for Molecular Radiotherapy by Taprogge, J., Wadsley, J., Miles, E., Flux, G.D.

“…Multicentre clinical trials involving a dosimetry component are becoming more prevalent in molecular radiotherapy and are essential to generate the evidence to…”
Get full text

Dosimetric Analysis of Individual Liver Metastases from Colorectal Cancer Following 90 y Microsphere Selective Internal Radiation Therapy by Abbott, E.M., Falzone, N., Winter, H., Greenhalgh, T.A., Kartsonaki, C., Craig, A.J., Denis-Bacelar, A., Flux, G.D., Sharma, R.A., Vallis, K.A.

Get full text

Dosimetric Analysis of Individual Liver Metastases from Colorectal Cancer Following 90y Microsphere Selective Internal Radiation Therapy by Abbott, E.M., Falzone, N., Winter, H., Greenhalgh, T.A., Kartsonaki, C., Craig, A.J., Denis-Bacelar, A., Flux, G.D., Sharma, R.A., Vallis, K.A.

Get full text

51 Uncertainties in standard uptake values from PET/CT by Gregory, R.A., Partridge, M., Cook, G., Flux, G.D.

Get full text

DETECT-dual energy transmission estimation CT-for improved attenuation correction in SPECT and PET by Guy, M.J., Castellano-Smith, I.A., Flower, M.A., Flux, G.D., Ott, R.J., Visvikis, D.

“…Accurate attenuation correction is a vital component of any quantitative emission CT (ECT) study, especially /sup 131/I-mIBG SPECT where accurate activity…”
Get full text

Multicellular dosimetry in voxel geometry for targeted radionuclide therapy by Malaroda, A, Flux, G D, Buffa, F M, Ott, R J

“…A software package to investigate absorbed doses and dose-rates at the cellular and multicellular scale has been developed that considers two- and…”
Get more information

Imaging dose: calibration of polymer gel dosimeters for use in targeted radionuclide therapy by Gear, J.I., Flux, G.D., Charles-Edwards, E., Partridge, M., Cook, G., Ott, R.J.

“…There is a lack of standardised methodology to perform dose calculations for targeted radionuclide therapy and at present no method exists to objectively…”
Get full text

Are 18fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses? by Maisey, N.R., Hill, M.E., Webb, A., Cunningham, D., Flux, G.D., Padhani, A., Ott, R.J., Norman, A., Bishop, L.

“…Treatment of both Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL) frequently results in a residual mass visible radiologically. Such patients may…”
Get full text

Monte Carlo simulation of /sup 90/Y Bremsstrahlung imaging by Heard, S., Flux, G.D., Guy, M.J., Ott, R.J.

“…Bremsstrahlung imaging can be used for the dosimetry of radionuclide therapies with pure beta emitters such as /sup 90/Y. However, the acquired spectrum is…”
Get full text

A novel high-energy I-131 scatter correction technique which includes correction for gamma camera scatter by Guy, M.J., Flux, G.D., Flower, M.A., Ott, R.J.

“…The performance of conventional Triple Energy Window (TEW) scatter correction for high-energy /sup 131/I studies can be improved, in some cases, by altering…”
Get full text

Practical scatter-independent gamma camera dead-time correction for iodine-131 by Guy, M.J., Flux, G.D., Flower, M.A., Ott, R.J., Papavasileiou, P., Chittenden, S.J.

“…Dead-time estimation is an important stage in the overall quantification of therapeutic gamma camera images. Up to 3 GBq of /sup 131/I was imaged under four…”
Get full text

DETECT-dual energy transmission estimation CT-for improved attenuation correction in SPECT and PET by Guy, M.J., Castellano-Smith, I.A., Flower, M.A., Flux, G.D., Ott, R.J., Visvikis, D.

“…Accurate attenuation correction is a vital component of any quantitative Emission CT (ECT) study, especially /sup 131/I-mIBG SPECT where accurate activity…”
Get full text